(Q46915052)

English

Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: a novel functional target for gefitinib

scientific article published in February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16441427

Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: a novel functional target for gefitinib (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16441427

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Hiroaki Sakurai

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16441427

author name string

Mitsuhiro Matsuo

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16441427

Yoko Ueno

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16441427

Osamu Ohtani

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16441427

Ikuo Saiki

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16441427

publication date

1 February 2006

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16441427

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16441427

97

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16441427

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16441427

155-162

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16441427

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

EGFR and cancer prognosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

The epidermal growth factor receptor and its inhibition in cancer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

EGF receptor in neoplasia and metastasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Induction of the estrogen receptor by ablation of DNMT1 in ER-negative breast cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Selective inhibition of TNF-alpha-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Fibronectin in malignancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Emerging views of integrin signaling: implications for prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Interaction of the integrin beta1 cytoplasmic domain with ICAP-1 protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Integrin alpha5/beta1 mediates fibronectin-dependent epithelial cell proliferation through epidermal growth factor receptor activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

p38 MAP kinase signaling is necessary for rat chondrosarcoma cell proliferation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

U0126, a mitogen-activated protein kinase kinase inhibitor, inhibits the invasion of human A375 melanoma cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Arg-Gly-Asp: a versatile cell recognition signal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Integrin regulation of epidermal growth factor (EGF) receptor and of EGF-dependent responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

A new pseudo-peptide analogue of the Arg-Gly-Asp (RGD) sequence inhibits liver metastasis of colon 26-L5 carcinoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00152.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2006.00152.X

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16441427

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16441427

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46915052&oldid=2137667771"